Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists map Brain's secret communication channels

NCT ID NCT04175119

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to understand how different parts of the brain send information to each other. Researchers used brain scans and mild electrical stimulation in 157 healthy adults to test a theory about brain waves. The findings may help future research on brain disorders.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

157 people

The number who actually took part.

Started

Nov 2019

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 36 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 20-36 years old * Right handed * Registered with the French healthcare system * Motivated to participate in the study * Normal or corrected vision * Adequate knowledge of French to be able to follow directions and give informed consent * Capacity to listen and follow study instructions * Use of contraception (in sexually active women) * BMI between 18.5 and 30 * Informed consent for participation in the study Exclusion Criteria: * For All Experiments: * Persons with : * Sleep disorders, neurological or psychiatric illnesses or a history of such problems that could impact quality/variability of data or cooperation and retention of the subject in the study * Migraines or light-sensitive epilepsy * Regular use of medications that impact the central nervous system * Regular use of medications, such as opioids and antidepressants, including Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants * Severe hearing loss * Skin conditions or allergies * Chronic pain, or any other medical conditions conducive to pain sensitivity * A history of stroke or recent trauma to the head * A pacemaker, insulin or other pump, neurostimulator, cochlear implants or other hearing aid, metal stents, prosthesis, or implants, intracerebral clips, implantable defibrillator, cerebral shunt or ventricular catheter, other foreign metal objects in the upper part of the body * Persons unable to adhere to abstinence from the use of drugs or alcohol the day or evening before experimental sessions * Women who are pregnant, breastfeeding, or have given birth in the last 6 months For experiments using magnetoencephalography: * Persons with * claustrophobia * any dental apparatus containing metal including or root canals * any foreign metallic object anywhere in the body * bolts, screws * orthopedic devices or implants * glasses (given the participant cannot use contact lenses) * a head size incompatible with the use of a personalized 3D head-cast or a magnetoencephalograph * Persons having had any surgery prior to the study which puts them at risk for metal objects left in the body For experiments using Magnetic Resonance Imaging (MRI) or Functional Magnetic Resonance Imaging (fMRI) techniques: * Anxious, non-cooperative, or agitated persons * Claustrophobia * Persons having had any surgery prior to the study which puts them at risk for metal objects left in the body For experiments using transcranial stimulation: -Persons with frequent syncope episodes (loss of consciousness) as a result of any particular sensorial stimulations

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy volunteer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre de Recherche en Neuroscience de Lyon INSERM

    Bron, 69500, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.